Dipeptidyl-Peptidase IV Inhibitors

Known as: Dipeptidyl-Peptidase 4 Inhibitors, Inhibitors, Dipeptidyl-Peptidase IV, Dipeptidyl Peptidase 4 Inhibitors 
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
To the Editor: The position statement of the American Diabetes Association (ADA) and the European Association for the Study of… (More)
Is this relevant?
Review
2010
Review
2010
Type 2 diabetes (T2DM) is a complex disease combining defects in insulin secretion and insulin action. New compounds have been… (More)
Is this relevant?
2009
2009
The incidence of diabetes is increasing and affects 180 million adults worldwide, including 24 million in the United States, or 7… (More)
Is this relevant?
Review
2008
Review
2008
Current type 2 diabetes therapies are mainly targeted at stimulating pancreatic beta-cell secretion and reducing insulin… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The incretin effect denominates the phenomenon that oral glucose elicits a higher insulin response than intravenous glucose… (More)
Is this relevant?
Review
2006
Review
2006
Glucagon-like peptide-1 is an insulinotropic hormone with antidiabetic potential due to its spectrum of effects, which include… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Analysis of plasma B-type natriuretic peptide (BNP) has suggested the in vivo formation of a truncated form, BNP (3-32… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Review
2005
Review
2005
The sole application of an inhibitor of the dipeptidyl peptidase DP IV (also DP 4, CD26, DPP-IV or DPP-4) to a mammal… (More)
Is this relevant?
Review
2003
Review
2003
Dipeptidyl-peptidase IV/CD26 (DPP IV) is a cell-surface protease belonging to the prolyloligopeptidase family. It selectively… (More)
Is this relevant?
Review
1998
Review
1998
The insulinotropic hormone, glucagon-like peptide 1 (GLP-1), which has been proposed as a new treatment for type 2 diabetes, is… (More)
Is this relevant?